Advertisement
Home »

Edoxaban Not Inferior to Warfarin in CTEPH Treatment

Jan 07, 2024

REFERENCES & ADDITIONAL READING

Hosokawa K, et al. A multicenter, randomized, warfarin-controlled trial of edoxaban in patients with chronic thromboembolic pulmonary hypertension: KABUKI trial. FS07, AHA Scientific Sessions 2023, 10–12 November 10-12, 2023, Philadelphia, PA, USA.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement